US 11072781
Genomic engineering of pluripotent cells
granted A61KA61K2035/124A61K2239/31
Quick answer
US patent 11072781 (Genomic engineering of pluripotent cells) held by Fate Therapeutics, Inc. expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2035/124, A61K2239/31, A61K2239/38, A61K40/10